Mar. 21 at 12:50 PM
$CYDY The FDA does not typically publish specific, individual patient compassionate use (expanded access) protocols, as these are confidential medical records, but they do publish aggregate data and trends regarding requests.
___
Abstract is his previous un-published work that Cytodyn initially referenced, becoming known.
Also giving a treating physcian, verifiable reasoning to a patient & FDA, on pre-dosing with Leronlimab.
Pre-dosing Leronlimab on Glioblastoma surgeries, could absolutely have started after Dr. Pestell’s GBM results.
Monday we find out why he was too focused on publically attaching his employment @ Cytodyn.
...